BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8962438)

  • 1. [Alterations in brain distribution of methamphetamine in methamphetamine-sensitized animals].
    Mizugaki M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Oct; 16(5):187-91. PubMed ID: 8962438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography study of the alterations in brain distribution of [11C]methamphetamine in methamphetamine-sensitized dog.
    Nakamura H; Hishinuma T; Tomioka Y; Ido T; Iwata R; Funaki Y; Itoh M; Fujiwara T; Yanai K; Sato M; Numachi Y; Yoshida S; Mizugaki M
    Ann N Y Acad Sci; 1996 Oct; 801():401-8. PubMed ID: 8959054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Positron emission tomography (PET) study of the alterations in brain pharmacokinetics of methamphetamine in methamphetamine sensitized animals].
    Nakamura H
    Yakugaku Zasshi; 2001 Aug; 121(8):585-91. PubMed ID: 11523119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of haloperidol and cocaine pretreatments on brain distribution and kinetics of [11C]methamphetamine in methamphetamine sensitized dog: application of PET to drug pharmacokinetic study.
    Nakamura H; Hishinuma T; Tomioka Y; Ishiwata S; Ido T; Iwata R; Funaki Y; Itoh M; Fujiwara T; Yanai K; Sato M; Numachi Y; Yoshida S; Mizugaki M
    Nucl Med Biol; 1997 Feb; 24(2):165-9. PubMed ID: 9190247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography (PET) study of the alterations in brain distribution of [11C]methamphetamine in methamphetamine sensitized dog.
    Mizugaki M; Nakamura H; Hishinuma T; Tomioka Y; Ishiwata S; Suzuki H; Ido T; Iwata R; Funaki Y; Itoh M
    Nucl Med Biol; 1995 Aug; 22(6):803-7. PubMed ID: 8535342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein expression profile in the amygdala of rats with methamphetamine-induced behavioral sensitization.
    Iwazaki T; McGregor IS; Matsumoto I
    Neurosci Lett; 2008 Apr; 435(2):113-9. PubMed ID: 18346852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein expression profile in the striatum of rats with methamphetamine-induced behavioral sensitization.
    Iwazaki T; McGregor IS; Matsumoto I
    Proteomics; 2007 Apr; 7(7):1131-9. PubMed ID: 17351886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of 5-HT receptors in the development and expression of methamphetamine-induced behavioral sensitization: 5-HT receptor channel and binding study.
    Yoo JH; Cho JH; Yu HS; Lee KW; Lee BH; Jeong SM; Nah SY; Kim HC; Lee SY; Jang CG
    J Neurochem; 2006 Nov; 99(3):976-88. PubMed ID: 16942594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of N-acetyl-L-cysteine on the reduction of brain dopamine transporters in monkey treated with methamphetamine.
    Hashimoto K; Tsukada H; Nishiyama S; Fukumoto D; Kakiuchi T; Shimizu E; Iyo M
    Ann N Y Acad Sci; 2004 Oct; 1025():231-5. PubMed ID: 15542721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in rats.
    Tsukamoto T; Iyo M; Tani K; Sekine Y; Hashimoto K; Ohashi Y; Suzuki K; Iwata Y; Mori N
    Psychopharmacology (Berl); 2001 Nov; 158(2):107-13. PubMed ID: 11702083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist.
    Shuto T; Kuroiwa M; Hamamura M; Yabuuchi K; Shimazoe T; Watanabe S; Nishi A; Yamamoto T
    Neuropharmacology; 2006 Jun; 50(8):991-7. PubMed ID: 16563442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in biodistribution of 11C-methamphetamine (MAP), 14C-MAP, and 123I-N-isopropyl-iodoamphetamine (IMP) in MAP- and cocaine-sensitized animals.
    Numachi Y; Yoshida S; Inosaka T; Sato M; Mizugaki M; Kimura K; Hishinuma T
    Ann N Y Acad Sci; 1992 Jun; 654():153-9. PubMed ID: 1632580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methamphetamine-induced hyperactivity and behavioral sensitization in PACAP deficient mice.
    Fujii H; Ishihama T; Ago Y; Shintani N; Kakuda M; Hashimoto H; Baba A; Matsuda T
    Peptides; 2007 Sep; 28(9):1674-9. PubMed ID: 17658665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual alteration of limbic dopamine D1 receptor-mediated signalling and the Akt/GSK3 pathway in dopamine D3 receptor mutants during the development of methamphetamine sensitization.
    Chen PC; Lao CL; Chen JC
    J Neurochem; 2007 Jan; 100(1):225-41. PubMed ID: 17101033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain and heart specific alteration of methamphetamine (MAP) distribution in MAP-sensitized rat.
    Nakagawa N; Hishinuma T; Nakamura H; Yamazaki T; Tsukamoto H; Hiratsuka M; Ido T; Mizugaki M; Terasaki T; Goto J
    Biol Pharm Bull; 2003 Apr; 26(4):506-9. PubMed ID: 12673033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug interaction between methamphetamine and antihistamines: behavioral changes and tissue concentrations of methamphetamine in rats.
    Okuda T; Ito Y; Nakagawa N; Hishinuma T; Tsukamoto H; Iwabuchi K; Watanabe T; Kitaichi K; Goto J; Yanai K
    Eur J Pharmacol; 2004 Nov; 505(1-3):135-44. PubMed ID: 15556146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic behavioral changes of methamphetamine in methamphetamine-sensitized animal model].
    Kitaichi K; Morishita Y; Hasegawa T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Nov; 21(5):133-44. PubMed ID: 11797416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine.
    Fukami G; Hashimoto K; Koike K; Okamura N; Shimizu E; Iyo M
    Brain Res; 2004 Jul; 1016(1):90-5. PubMed ID: 15234256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
    Shuto T; Seeman P; Kuroiwa M; Nishi A
    Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
    Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
    Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.